DAVID HUANG,GERHARD GUSTAV STEINMANN,JERRY O. STERN
申请号:
BRPI0918653
公开号:
BRPI0918653A2
申请日:
2009.09.14
申请国别(地区):
BR
年份:
2015
代理人:
摘要:
The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.